Spatial Transcriptomics of Intraductal Papillary Mucinous Neoplasms of the Pancreas Identifies NKX6-2 as a Driver of Gastric Differentiation and Indolent Biological Potential
Marta Sans(The University of Texas MD Anderson Cancer Center), Anirban Maitra(The University of Texas Southwestern Medical Center)
Cited by 59
Related Papers
Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer
|Journal for ImmunoTherapy of Cancer|2020|91
Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alteration
|bioRxiv (Cold Spring Harbor Laboratory)|2023|7